Last update Jan. 4, 2020
Very High Risk
A parasitic fungus from the ear of some cereals, particularly rye, which since ancient times has caused epidemics of a serious disease, ergotism (Florea 2017, Belser 2013, Lee 2009).
It has a complex composition, highlighting the ergoline alkaloids: lysergic acid amides such as ergometrine and ergopeptines such as ergotamine and ergotoxine (Florea 2017, Hulvová 2013) that act on adrenergic, dopaminergic and serotonergic receptors.
Since the last update, we have not found published data on its excretion in breast milk.
Ergot alkaloids have oxytocic, vasoconstrictive and lactation-inhibiting effects by inhibiting prolactin, among many others (Florea 2017, Hulvová 2013, Lee 2010, Lee 2009).
Indications from the German Ministry of Health’s Commission E: none.
Due to its serious adverse reactions and toxicity, natural alkaloids are not used in therapy, and there are recommendations for their withdrawal from sale (EMA 2014).
Withdrawal or restricted from the market in Spain (MSC 2004).
At present, semisynthetic derivatives such as methylergometrine, dihydroergotamine, dihydroergocristine, bromocriptine and lisuride are used, among others.
We do not have alternatives for Ergot de seigle.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM